David Zelmanovic
Impact in
- Hematology top 2%
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
- Blood groups and transfusion
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in ⓘ
-
- Venous Thromboembolism Diagnosis and Management 3
-
- Platelet Disorders and Treatments 6
- Iron Metabolism and Disorders 2
- Co-authors
- David Okrongly (4 shared papers)Emma Chapman (3 shared papers)Lee Webb (3 shared papers)Adrian C. Newland (3 shared papers)David S. Rampton (2 shared papers)E Carty (2 shared papers)M. G. Macey (2 shared papers)Rajanna Sreedhara (1 shared paper)
- Journals
- American Journal of Clinical Pathology (3 papers)Cytometry (2 papers)Clinical Chemistry (1 paper)Thrombosis and Haemostasis (1 paper)American Journal of Kidney Diseases (1 paper)
- Partner nations
- United StatesUnited KingdomBulgaria
In The Last Decade
David Zelmanovic
12 papers receiving 665 citations
Peers
Comparison fields: 5 of 86
- Hematology 392
- Internal Medicine 86
- Equine 27
- Genetics 151
- Biochemistry 48
Countries citing papers authored by David Zelmanovic
This map shows the geographic impact of David Zelmanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zelmanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zelmanovic more than expected).
Fields of papers citing papers by David Zelmanovic
This network shows the impact of papers produced by David Zelmanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zelmanovic. The network helps show where David Zelmanovic may publish in the future.
Co-authors
The 25 scholars most cited alongside David Zelmanovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 124 | |
| 2 | 1997 | 117 | |
| 3 | 1999 | 73 | |
| 4 | 1999 | 69 | |
| 5 | 1998 | 63 | |
| 6 | 1997 | 60 | |
| 7 | 2000 | 60 | |
| 8 | 2006 | 46 | |
| 9 | 2003 | 40 | |
| 10 | 2001 | 13 | |
| 11 | 2014 | 12 | |
| 12 | 2008 | 9 |
About David Zelmanovic
David Zelmanovic is a scholar working on Internal Medicine, Hematology, Genetics, Emergency Medicine and Oncology, having authored 12 papers that have together received 686 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Hemoglobinopathies and Related Disorders (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Blood properties and coagulation (3 papers), Iron Metabolism and Disorders (2 papers), Hematological disorders and diagnostics (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Hematology (392 citations), Internal Medicine (86 citations), Equine (27 citations), Genetics (151 citations) and Biochemistry (48 citations). David Zelmanovic has collaborated with scholars based in United States, United Kingdom and Bulgaria. Frequent co-authors include David Okrongly, Emma Chapman, Lee Webb, Adrian C. Newland, David S. Rampton, E Carty, M. G. Macey, Rajanna Sreedhara, Morrell M. Avram and Martin Sorette. Their work appears in journals such as American Journal of Clinical Pathology, Cytometry, Clinical Chemistry, Thrombosis and Haemostasis and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.